-

AscellaHealth Designates Preferred Status to Leading Pharmacies for Home Infusion Pharmacy Network, Enhances Site of Care Optimization

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global specialty pharmacy and healthcare solutions company, is pleased to announce that Amber Specialty Pharmacy, AcariaHealth and BioMatrix Specialty Pharmacy are preferred partners within its Home Infusion Pharmacy Network. These designations are part of AscellaHealth’s Site of Care Optimization (SOC) initiative and overall strategies designed to cut costs without compromising quality of care, which are critical for third-party payers.

“By selecting these top pharmacies for preferred status, we are taking an important step toward reducing the cost of specialty biologic medications and encouraging patients to move from higher-cost settings, like big hospitals and institutions, to lower-cost settings, such as physician’s in-office infusion suites or stand-alone infusion centers,” says Dea Belazi, president and CEO, AscellaHealth. “As part of our mission to help our clients better manage the high costs of specialty medication, this initiative exemplifies our efforts to increase care accessibility by encouraging the use of clinically appropriate, lower-cost care settings. The extensive range of these pharmacy sites that are dedicated to infusion therapy creates a better patient experience and improves outcomes.”

He adds that SOC optimization is particularly helpful for acute therapies, such as intravenous antibiotics or routine therapies for Crohn’s disease or rheumatoid arthritis, which can be safely and easily administered outside of the hospital or physician’s office settings.

The goals are to:

  • Improve drug affordability
  • Increase price transparency
  • Reduce disparities in quality of care and safety across care settings
  • Enable care delivery in the highest-quality, lowest-cost care setting
  • Increase patient convenience for enhanced compliance to therapy

Belazi adds, “With Amber Specialty Pharmacy, AcariaHealth and BioMatrix Specialty Pharmacy, we know that the therapies will be clinically appropriate and at a high level of quality that is equal to other sites of care. These pharmacists and nurses are highly trained, very experienced and well educated.”

About AscellaHealth LLC
AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving patients, payers, life sciences and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. An Inc. 5000 2021 winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Visit www.AscellaHealth.com.

201.641.1911 x 54

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com

AscellaHealth


Release Summary
AscellaHealth Designates Preferred Status to Leading Pharmacies for Home Infusion Pharmacy Network, Enhances Site of Care Optimization
Release Versions

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com

Social Media Profiles
More News From AscellaHealth

AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies...

AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies

DUBLIN--(BUSINESS WIRE)--AscellaHealth, a global partner delivering customisable solutions for the specialty pharmaceutical industry, proudly announces its role as Gold Sponsor of the World Orphan Drug Congress Europe (WODC), 22-25 October 2024, Barcelona, Spain. During the event, AscellaHealth will exhibit its comprehensive suite of end-to-end solutions proven to streamline the specialty pharmaceutical commercialisation process for life science manufacturers worldwide. These solutions align wi...

AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Issues Impacting Life Sciences & Payers within the Specialty Healthcare...
Back to Newsroom